Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases

Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.

6,127 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases trial results

Completed

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

NCT00000762

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 34 locations
View Trial Details
Completed

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

NCT00459316

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations
  • Usc La Nichd Crs Alhambra, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
  • Children's Hospital of Los Angeles NICHD CRS Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 37 locations
View Trial Details
Completed

A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

NCT00000947

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +28 more
Locations
  • Community Consortium / Jon Kaiser Wellness Ctr San Francisco, California, United States
  • Community Consortium / UCSF San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Washington Reg AIDS Prog / Dept of Infect Dis Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002

NCT00000682

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +24 more
Locations
  • USC CRS Los Angeles, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
View Trial Details
Completed

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

NCT00000656

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Palo Alto Veterans Adm Med Ctr / Stanford Univ Palo Alto, California, United States
  • Whitman - Walker Clinic Washington D.C., District of Columbia, United States
  • Univ of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Univ of Pittsburgh Med School Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

NCT00000729

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • USC School of Medicine / Norris Cancer Hosp Los Angeles, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Univ of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

NCT00000641

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • St. Louis ConnectCare, Infectious Diseases Clinic St Louis, Missouri, United States
  • Washington U CRS St Louis, Missouri, United States
View all 16 locations
View Trial Details

Related conditions